Sleep apnea decisions — 2026

The Board has decided to remand the case due to errors in development and insufficient opinions regarding service connection for obstructive sleep apnea, including its relationship to obesity and psychiatric disability.

The Board has denied the Veteran's claim for service connection for Obstructive Sleep Apnea, finding that it is not related to his active duty service or any service-connected disability.

The Veteran's claims for service connection for various conditions, including colon cancer, sleep apnea, respiratory disability, type II diabetes mellitus, enlarged prostate, diabetic neuropathy, heart disability, and acquired psychiatric disability were denied as there was no persuasive evidence to support the assertions.

The Veteran withdrew his appeals regarding benign paroxysmal positional vertigo, bilateral knee condition, headaches, obstructive sleep apnea, and diabetes mellitus type II.

The Board has granted service connection for sleep apnea as secondary to the Veteran's service-connected hypertension and residuals of a fractured right mandible with TMJ syndrome. The rating for the residuals of a fractured right mandible with TMJ syndrome remains remanded due to the need for an addendum VA medical opinion.

The Board has decided to remand the case due to incomplete medical records and requests for additional information. The Veteran's claim for service connection for sleep apnea is being returned for further action.

The Veteran's claims for service connection for gastroesophageal reflux disease (GERD) and obstructive sleep apnea were denied because the Veteran failed to report for scheduled VA examinations without providing a valid reason.

The Board has decided to remand the cases for further development due to a duty to assist error, specifically regarding Social Security Administration (SSA) records.

The Veteran's claims for prostate cancer, bilateral lower extremity radiculopathy of the sciatic nerve, and increased rating for IVDS have been granted. The effective dates are not specified as they were granted under direct service connection.

The Veteran withdrew his appeal, stating he no longer has any disabilities and wishes to discontinue VA disability benefits.

The Veteran's appeal is remanded for additional development to address incomplete service treatment records and clarify his periods of active duty, including his time in the Marine Corps Reserve. The rating for tinnitus remains denied as it already meets the maximum schedular evaluation.

The Veteran's service-connected disabilities do not meet the criteria for specially adapted housing (SAH) or special home adaptation (SHA) grants due to his existing conditions and ratings.

The Veteran's lumbosacral strain and MDD have been granted effective from the dates of their respective claims.,Service connection for peripheral neuropathy of the LUE, posttraumatic headaches, IBS, and left shoulder strain has not yet been established.

The Veteran's left shoulder arthroscopic labral tear repair with residual pain and decreased range of motion is granted a disability rating of 30 percent, but no higher. Other conditions are denied or not rated.

The Veteran's appeal for a higher disability rating for lumbosacral strain is remanded due to the failure of the RO to request VA treatment records from January 2018 through February 2020.

The Veteran's appeals for service connection and increased ratings on several conditions have been dismissed due to procedural issues. The claims were improperly docketed, leading to the dismissal of the appeal.

The Veteran's service-connected migraine headaches have aggravated his current diagnosis of sleep apnea, and the Board has granted service connection for this condition as secondary to his migraines.

The Veteran's lumbosacral strain with levoscoliosis is rated at 40 percent effective April 4, 2022.

Your appeal has been dismissed as the Veteran withdrew his appeal before the Board.

The Veteran's service connection for obstructive sleep apnea and cervical fusion as secondary to Parkinson's disease are granted, with an effective date of October 23, 2023.